Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Cohen

Showing results (61-70 of 867) with videos related to

Pageof 87
Sort By:
Journal of the American College of Cardiology|October 24, 2007
Vascular closure devices: the second decadeHarold L Dauerman, Robert J Applegate, David J Cohen
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 7, 2019
Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?Benjamin Z Galper, Suzanne J Baron, David J Cohen
Journal of the American Academy of Dermatology|February 21, 2006
The treatment of pyoderma gangrenosum using etanerceptDavid B Roy, Eugene T Conte, David J Cohen
Circulation|November 9, 2016
Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical RiskMatthew R Reynolds, Suzanne J Baron, David J Cohen
Journal of the American College of Cardiology|October 29, 2025
A Randomized Trial Evaluating the DAPT Score in Clinical Practice: The Ultimate Validation?Robert W Yeh, Eric A Secemsky, David J Cohen
Nature Reviews. Cardiology|August 10, 2011
Cost-effectiveness of oral antiplatelet agents--current and future perspectivesSuzanne V Arnold, David J Cohen, Elizabeth A Magnuson
Journal of the American College of Cardiology|November 27, 2024
The FINE ART of Interpreting Health Status Benefits in Clinical TrialsJohn A Spertus, David J Cohen, Suzanne V Arnold
The Journal of Dermatological Treatment|June 12, 2019
Treatment of acrodermatitis continua of hallopeau with ixekizumabAustinn C Miller, Timothy E Holland, David J Cohen
Journal of Cardiovascular Electrophysiology|April 25, 2007
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registryMatthew R Reynolds, Vidal Essebag, Peter Zimetbaum, et al.
European Heart Journal|January 29, 2016
TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantationRishi Puri, Bernard Iung, David J Cohen, et al.
Pageof 87

Showing results (61-70 of 867) with videos related to

Sort By:
Pageof 87
Journal of the American College of Cardiology|October 24, 2007
Vascular closure devices: the second decadeHarold L Dauerman, Robert J Applegate, David J Cohen
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 7, 2019
Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?Benjamin Z Galper, Suzanne J Baron, David J Cohen
Journal of the American Academy of Dermatology|February 21, 2006
The treatment of pyoderma gangrenosum using etanerceptDavid B Roy, Eugene T Conte, David J Cohen
Circulation|November 9, 2016
Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical RiskMatthew R Reynolds, Suzanne J Baron, David J Cohen
Journal of the American College of Cardiology|October 29, 2025
A Randomized Trial Evaluating the DAPT Score in Clinical Practice: The Ultimate Validation?Robert W Yeh, Eric A Secemsky, David J Cohen
Nature Reviews. Cardiology|August 10, 2011
Cost-effectiveness of oral antiplatelet agents--current and future perspectivesSuzanne V Arnold, David J Cohen, Elizabeth A Magnuson
Journal of the American College of Cardiology|November 27, 2024
The FINE ART of Interpreting Health Status Benefits in Clinical TrialsJohn A Spertus, David J Cohen, Suzanne V Arnold
The Journal of Dermatological Treatment|June 12, 2019
Treatment of acrodermatitis continua of hallopeau with ixekizumabAustinn C Miller, Timothy E Holland, David J Cohen
Journal of Cardiovascular Electrophysiology|April 25, 2007
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registryMatthew R Reynolds, Vidal Essebag, Peter Zimetbaum, et al.
European Heart Journal|January 29, 2016
TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantationRishi Puri, Bernard Iung, David J Cohen, et al.
Pageof 87